Drugs, Diseases, and the Managed Care Impact
- Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into IgA Nephropathy and Duchenne Muscular Dystrophy
- Rare Disease Spotlight: Disease Burden, Unmet Needs, and Amplifying the Patient Voice, Managed Care Insights into Sickle Cell Disease and Hemophilia
Keynote
- Oncology Pipeline 2025: Emerging Breakthroughs and Trends
- Unleashing the Power of AI: Transforming Healthcare and Pharmacy
Managed Care Research in Action
- Bridging the Gap: Applying the AMCP Real-World Evidence (RWE) Standards to Facilitate Communication Between Manufacturers and Payers
- Data Storytelling: Effective Communication with Payers and Other Audiences
Fundamentals of Managed Care

Facebook
X
LinkedIn
Forward